A new entrant to the field of CRISPR gene-editing, Copenhagen-based Twelve Bio, has been launched with the help of venture capital firm Arix Bioscience.
New Company Twelve Bio Aims To Improve On CRISPR Gene-Editing Tech
Cas12a Offers Advantages
Venture capital firm Arix is financing the Copenhangen, Denmark-based biotech, which is looking to play its part in the fast-maturing gene-editing field.
